New data from prospective, global, multicenter, double-blind ADVISE II Registry presented during Late-Breaking Clinical Trials Session at 25th Annual TCT Scientific Symposium SAN FRANCISCO, CA. -- ...
SAN DIEGO, May 21, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback